时间：2020-07-22 08:16:40人气：8601来源： 迪拜新闻网
File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)
A phase 2 trial of a COVID-19 vaccine candidate in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.
Viral Chongqing nightscape video wows viewers with vision of China's urban future
(4361)人喜欢2026-03-18
Chinese lawmakers approve 2026 central budget
(6005)人喜欢2026-03-12
China's GDP to grow by over 6 trillion yuan this year
(6007)人喜欢2026-03-07
Britain sending helicopters, warship to Cyprus: PM
(5461)人喜欢2026-03-04
2026 Zhongguancun Forum to be held in late March
(4417)人喜欢2026-02-26
China's Xuelong wraps up ocean mission in 42nd Antarctic expedition
(5023)人喜欢2026-02-22
Philippine VP Sara Duterte announces 2028 presidential bid
(4400)人喜欢2026-02-18
Chinese authorities launch investigation after fishing boat hits Bryde's whale
(4578)人喜欢2026-02-13